Hem › Akut myeloid leukemi › New Jersey › Edison
Kliniska studier för Akut myeloid leukemi i Edison, NJ
20 studier för Akut myeloid leukemi söker deltagare vid platser i och runt Edison (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
RekryterarFas 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RekryterarFas 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekryterarFas 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RekryterarFas 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
A Study of CRD3874-SI in People With Leukemia
RekryterarFas 1
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi bort
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RekryterarFas 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekryterarFas 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekryterarFas 3
- Saint Peter's University Hospital, New Brunswick · 3 mi bort
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi bort
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekryterarFas 1/2
- Saint Peter's University Hospital, New Brunswick · 3 mi bort
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi bort
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RekryterarFas 3
- Rutgers Biomedical and Health Sciences, New Brunswick · 3 mi bort
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
RekryterarFas 2
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi bort
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekryterarObservationsstudie
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · 3 mi bort
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
RekryterarFas 1
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
RekryterarFas 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi bort
A Study of Revumenib and Mezigdomide in People With Leukemia
RekryterarFas 1/2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi bort
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
RekryterarFas 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi bort
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekryterarFas 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekryterarFas 1
- Rutgers Cancer Institute, New Brunswick · 3 mi bort
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
RekryterarFas 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi bort
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
RekryterarFas 2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi bort
Akut myeloid leukemi-studier i andra städer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Baldwin Park, CA40 studier
- Seattle, WA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA30 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
Andra studier i Edison
- Bröstcancer68 studier
- Icke-småcellig lungcancer47 studier
- Cancer (alla typer)33 studier
- Prostatacancer29 studier
- Kolorektal cancer23 studier
- Lungcancer23 studier
- Multipelt myelom22 studier
- Blåscancer21 studier
- Metastaserande cancer20 studier
- Äggstockscancer20 studier
- Endometriecancer19 studier
- Urotelial (övergångscells-)karcinom18 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.